HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Background: Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer worldwide. Heat shock protein 90 alpha family class B member 1 (HSP90AB1) is highly expressed in a variety of cancers and is associated with poor prognosis, however, its role in HNSCC is still poorly understood. This study aimed to explore the function HSP90AB1 played in HNSCC progression. Methods: The expression level of HSP90AB1 in HNSCC was analyzed by bioinformatics analysis and western blotting, and its relationship with clinicopathological parameters was analyzed by bioinformatics analysis and immunohistochemistry. Three stable HSP90AB1 knockdown HNSCC cell lines were constructed by lentiviral transfection. The effect of HSP90AB1 knockdown on the proliferation and migration of HNSCC cells was tested by CCK-8 assay, EdU incorporation assay, colony formation assay, nude mouse xenograft models, transwell migration assay, wound healing assay, and western blotting. The effect of HSP90AB1 knockdown on glycolysis in HNSCC cells was assessed by quantitative real-time PCR and related assay kits. Finally, the levels of Akt and phospho-Akt (Ser473) proteins after HSP90AB1 knockdown were detected by western blotting. Results: HSP90AB1 was highly expressed in HNSCC and associated with T grade, lymph node metastasis, and prognosis. Knockdown of HSP90AB1 inhibited the proliferation, migration, and glycolysis of HNSCC, and reduced the level of phospho-Akt. Conclusion: HSP90AB1 functions as an oncogene in HNSCC, and has the potential to become a prognostic factor and therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple investigations have revealed that HSP90AB1 facilitates tumorigenesis in a spectrum of cancers, including gastric cancer, breast cancer, non-small cell lung cancer (NSCLC), hepatocellular carcinoma, and head and neck squamous cell carcinoma [13–18].”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849 · cited 1×
“The co-expression relationship between HSP90AB1 and various key proteins in the glycolysis pathway was obtained through Gene Expression Profiling Interactive Analysis (GEPIA).(28) Gene Set Enrichment Analysis (GSEA) was used to investigate the biological pathway difference between high and low HSP90AB1 patients.”
MethodHead and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Modulation of Akt kinase activity by binding to Hsp90
Sato, S., Fujita, N., & Tsuruo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170276797 · Cited by 967
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Feng, J., Li, J., Wu, L., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01629-4 · Cited by 699
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Hoter, A., El-Sabban, M. E., & Naim, H. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092560 · Cited by 693 · cited 1×
“14–16 In mammalian cells, HSP90 has 4 subtypes: heat shock protein 90 alpha family class A member 1 (HSP90AA1), heat shock protein 90 alpha family class B member 1 (HSP90AB1), glucose-regulated protein 94 (GRP94), and TNF receptorassociated protein 1 (TRAP1).(17) Previous studies mainly focused on HSP90 as a whole, an…”
BackgroundRoles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514 · cited 1×
“The PI3K-Akt-mTOR pathway is an important upstream pathway of glycolysis.(30) Therefore, we detected the protein expression levels of pan-Akt and phospho-Akt (Ser473) in 3 HNSCC cell lines and found that there was no visible change in the expression of pan-Akt after HSP90AB1 knockdown, while the expression of phospho-…”
BackgroundHigh HSP90 Expression Is Associated with Decreased Survival in Breast Cancer
Pick, E., Kluger, Y., Giltnane, J. M., Moeder, C., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4511 · Cited by 356
Xu, Q., Tu, J., Dou, C., Zhang, J., Yang, L., Liu, X., Lei, K., Liu, Z., Wang, Y., Li, L., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0748-y · Cited by 283
The Warburg metabolism fuels tumor metastasis
Lu, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09794-5 · Cited by 218
HSP90AB1: Helping the good and the bad
Haase, M., & Fitze, G. (2016) · Gene · doi:10.1016/j.gene.2015.08.063 · Cited by 179
Ohkubo, S., Kodama, Y., Muraoka, H., Hitotsumachi, H., Yoshimura, C., Kitade, M., Hashimoto, A., Ito, K., Gomori, A., Takahashi, K., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0219 · Cited by 145
Sandulache, V. C., Ow, T. J., Pickering, C. R., Frederick, M. J., Zhou, G., Fokt, I., Davis‐Malesevich, M., Priebe, W., & Myers, J. N. (2011) · Cancer · doi:10.1002/cncr.25868 · Cited by 143
Spotlight on 17‐ AAG as an Hsp90 inhibitor for molecular targeted cancer treatment
Talaei, S., Mellatyar, H., Asadi, A., Akbarzadeh, A., Sheervalilou, R., & Zarghami, N. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13486 · Cited by 143
Combination therapies with HSP90 inhibitors against colorectal cancer
Kryeziu, K., Bruun, J., Guren, T. K., Sveen, A., & Lothe, R. A. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.002 · Cited by 127
Biaoxue, R., Xiling, J., Shuanying, Y., Wei, Z., Xiguang, C., Jinsui, W., & Min, Z. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-70 · Cited by 122
Wang, H., Deng, G., Ai, M., Xu, Z., Mou, T., Yu, J., Liu, H., Wang, S., & Li, G. (2019) · Oncogene · doi:10.1038/s41388-018-0532-5 · Cited by 117
Hamamoto, R., Toyokawa, G., Nakakido, M., Ueda, K., & Nakamura, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.014 · Cited by 110
Cao, X., Bloomston, M., Zhang, T., Frankel, W. L., Jia, G., Wang, B., Hall, N. C., Koch, R. M., Cheng, H., Knopp, M. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1607 · Cited by 89
Expression of hsp90 and cyclin D1 in human breast cancer
Yano, M., Naito, Z., Yokoyama, M., Shiraki, Y., Ishiwata, T., Inokuchi, M., & Asano, G. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00338-3 · Cited by 86
Lee, S., Jee, J., Bae, J., Liu, K., & Lee, Y. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24813 · Cited by 86
Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis
Ashrafian, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68228-7 · Cited by 82
Montani, M. S. G., Cecere, N., Granato, M., Romeo, M. A., Falcinelli, L., Ciciarelli, U., D’Orazi, G., Faggioni, A., & Cirone, M. (2019) · Cancers · doi:10.3390/cancers11050703 · Cited by 70
Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
Meng, J., Liu, Y., Han, J., Tan, Q., Chen, S., Qiao, K., Zhou, H., Sun, T., & Yang, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0640-9 · Cited by 68
Canella, A., Welker, A. M., Yoo, J. Y., Xu, J., Abas, F. S., Kesanakurti, D., Nagarajan, P., Beattie, C. E., Sulman, E. P., Liu, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3151 · Cited by 67
Yin, X., Han, S., Song, C., Zou, H., Wei, Z., Xu, W., Ran, J., Tang, C., Wang, Y., Cai, Y., et al. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00446-y · Cited by 55
Self-citationXu, E., Xia, X., Jiang, C., Li, Z., Yang, Z., Zheng, C. J., Wang, X., Du, S., Miao, J., Wang, F., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.591239 · Cited by 51
Liu, Q., Wang, Z., Zhou, X., Tang, M., Tan, W., Sun, T., Wang, Y., & Deng, Y. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00730-8 · Cited by 49
Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma
Westekemper, H., Karimi, S., Süßkind, D., Anastassiou, G., Freistuehler, M., Steuhl, K., Bornfeld, N., Schmid, K. W., & Grabellus, F. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.183939 · Cited by 38
Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma
Liu, Z., Li, H., He, L., Xiang, Y., Tian, C., Li, C., Tan, P., Ji, J., Tian, Y., Du, L., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2018.11.009 · Cited by 37
Park, S., Park, J.-A., Yoo, H., Park, H.-B., & Lee, Y. (2017) · Redox Biology · doi:10.1016/j.redox.2017.07.010 · Cited by 37
Yang, J., Wang, W., Xia, H.-F., Yu, Z., Li, H., Ren, J., Chen, G., Wang, B., Jia, J., Zhang, W., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32221 · Cited by 37
Lee, Y., Chang, W., Chen, Y.-Y., Tsai, Y.-H., Chou, Y., Tseng, H., Chen, H.-L., Wu, C., Chang‐Chien, J., Lee, H., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091986 · Cited by 33
Lin, T., Qiu, Y., Peng, W., & Peng, L. (2020) · BioMed Research International · doi:10.1155/2020/2148253 · Cited by 31
Liu, Y., & Yin, S. (2020) · Journal of Oncology · doi:10.1155/2020/7353874 · Cited by 26
PML / RARA inhibits expression of HSP 90 and its target AKT
Piredda, M. L., Gaur, G., Catalano, G., Divona, M., Banella, C., Travaglini, S., Puzzangara, M. C., Voso, M. T., Lo‐Coco, F., & Noguera, N. I. (2018) · British Journal of Haematology · doi:10.1111/bjh.15715 · Cited by 24
Crouch, B. T., Murphy, H., Belonwu, S. A., Martinez, A. F., Gallagher, J., Hall, A. H. S., Soo, M. S., Lee, M., Hughes, P. F., Haystead, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17832-x · Cited by 18
Subramanian, C., Gorney, R., Wang, T., Ge, D., Zhang, N., Zuo, A., Blagg, B. S. J., & Cohen, M. S. (2020) · Surgery · doi:10.1016/j.surg.2020.06.009 · Cited by 13
Biaoxue, R., Xiguang, C., Liu, H., Fu, T., Gao, W., Zhao, C., & Lin, Y. (2016) · PubMed Central · Cited by 12
Biaoxue, R., Min, L., Fu, T., Wenlong, G., & Hua, L. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0752-z · Cited by 11
Cited by
Regulatory Mechanism of Protein Crotonylation and Its Relationship with Cancer
Yang, S., Fan, X., & Yu, W. (2024) · Cells · doi:10.3390/cells13211812 · Cited by 29
Xu, L., Liu, Y.-H., Zhang, H.-Q., Wu, L., Li, Q., Deng, J., Zhang, Q., Yang, Y., Zhang, C., Li, Y.-L., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03047-w · Cited by 23
Self-citationLing, J., Zhang, L., Wang, Y., Chang, A., Huang, Y. F., Zhao, H., & Zhuo, X. (2023) · Phytotherapy Research · doi:10.1002/ptr.7723 · Cited by 18
Liu, J., Yu, H., Yu, S., Liu, M., Chen, X., Wang, Y., Li, J., Caixing, S., Liu, W., Zuo, Z., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75874-4 · Cited by 15
Xiong, Y., Zhou, F., Zhou, J.-W., Liu, F., Zhou, S., Li, B., Liu, Z.-J., & Yang, Q. (2023) · Current Genomics · doi:10.2174/0113892029277262231108105441 · Cited by 14
Metadata
- Authors
- Zhang, H., Yin, X., Zhang, X., Zhou, M., Xu, W., Wei, Z., Song, C., Han, S., & Han, W.
- Affiliations
- Nanjing University (CN)
- Xuzhou Medical College (CN)
- Corresponding author
- Zhang, Hongbo
- Yin, Xiteng
- Han, Shengwei
- Han, Wei
- Venue
- Technology in Cancer Research & Treatment
- Publisher
- SAGE Publications
- Published
- 2022-08-05
- Volume
- 21
- Pages
- 15330338221118202-15330338221118202
- ISSN
- 1533-0338 (ISSN-L)
- 1533-0346
- PMC
- PMC9358565
- OpenAlex
- W4289860376
- Cited by
- 40
- References
- 45
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 12 · 2023: 8
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Technology in Cancer Research & Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Jiangsu Province (BK20210080)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- HSP90AB1, head and neck squamous cell carcinoma, oncogenes, cell proliferation, cell migration, glycolysis, Akt signaling, prognostic factors, therapeutic target, lymph node metastasis
- MeSH terms
- Squamous Cell Carcinoma of Head and Neck, Animals, Cell Movement, Glycolysis, Head and Neck Neoplasms, Humans, Prognosis, HSP90 Heat-Shock Proteins, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.